Searched for
CASIRIVIMAB
WHO 'strongly advises against' use of two COVID-19 antibody therapies, says British Medical JournalThe WHO Guideline Development Group of international experts noted that antibody drugs sotrovimab and casirivimab-imdevimab are not recomme...- US FDA study warns against certain treatments for Omicron. Details hereWith the continuous rise in Omicron cases of Covid-19, patients are looking at various drug options to relieve some symptoms. US-based infe...
- USFDA revokes emergency use status to two Covid antibody therapies"Because data show these treatments are highly unlikely to be active against the omicron variant, which is circulating at a very high frequ...
- Which medicine works best for Covid-19 treatment? WHO answersFor those infected, it is important to know your best treatment options -- the right medicines and drugs that have been effective in reduci...
- Health insurers can't reject Covid claims for antibody cocktail therapy: IrdaiInsurers have been ordered by the regulator to assess claims denied or deductions made in all such cases and take appropriate action to pay...
- Covid cases on the rise, experts call for newer drugs, faster approvalsThe Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moder...
- 8 vaccines, 4 treatments in India's COVID-19 arsenalMeanwhile, India logged 653 cases of the Omicron variant of coronavirus across 21 states and UTs so far out of which 186 have recovered or ...
- CBIC notifies GST hike on green gear including solar panelsSolar panels and modules, bio-gas plants, solar power generators, windmills, solar lamps, tidal waves energy devices or plants and their pa...
- WHO recommends antibody treatment for critical Covid patientsThe WHO Guideline Development Group (GDG) panel recommends treatment combining casirivimab and imdevimab for two specific groups of patient...
- Delta plus: New Covid variant identified, experts say no cause of concern for nowThough there is no indication yet of the severity of the disease due to the new variant, Delta plus is resistant to the monoclonal antibody...
- Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
- Doctors call monoclonal antibody cocktail ‘first Covid treatment’The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works ju...
- COVID-19: Antibody cocktail treatment begins at Delhi's Sir Ganga Ram HospitalThe hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at...
- 72-year-old Covid patient given 'antibody cocktail' at Fortis in MohaliThe Mohali-based Fortis Hospital, in a statement, said the patient, who had tested positive for the infection two days ago, is a diabetic w...
- 65 yr old man becomes 1st Covid patient to get antibody cocktail at Apollo in DelhiAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...
- Fortis hospital in Delhi offers monoclonal antibody therapy; awaits takersAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms are offered a cocktail of Casirivimab and Imd...
- Cipla to market Roche's Antibody Cocktail in IndiaCipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint stateme...
- India got 5.5 lakh Remdesivir vials, 15,801 oxygen cylinders as foreign aid: CentreThrough a streamlined and systematic mechanism, various ministries and departments have seamlessly collaborated under the 'whole of governm...
- Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...
- Roche reports promising results from anti-Covid cocktailThe results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab "reduced hospitalisation or death ...
Load More
